ALDOSTERONE ANTAGONIST AND NON-STEROIDAL ANTIINFLAMMATORY AGENT COMBINATION THERAPY TO PREVENT OR TREAT CARDIOVASCULAR DISORDERS

Details for Australian Patent Application No. 2003207773 (hide)

Owner PHARMACIA CORPORATION

Inventors MCMAHON, Ellen, G.; ROCHA, Ricardo

Pub. Number AU-A-2003207773

PCT Number PCT/US03/02923

PCT Pub. Number WO2003/063908

Priority 60/353,008 30.01.02 US

Filing date 30 January 2003

Wipo publication date 2 September 2003

International Classifications

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/585

A61K 031/58 - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 009/00 Drugs for disorders of the cardiovascular system

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/353,008 30.01.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2003207773

15 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003207774-PESTALOTIOPSIS MICROSPORIA ISOLATES AND COMPOUNDS DERIVED THEREFROM

2003207772-DISCONTINUOUS TRANSMISSION (DTX) DETECTION